The Open Rheumatology Journal




ISSN: 1874-3129 ― Volume 13, 2019

MEFV Variants in Patients with PFAPA Syndrome in Japan



Shoichiro Taniuchi*, 1 , Ryuta Nishikomori 2, Anna Iharada 1, Shoji Tuji 1, Toshio Heike 2, Kazunari Kaneko 1
1 Department of Pediatrics, Kansai Medical University, Japan
2 Department of Pediatrics, Kyoto University, Japan

Abstract

Background:

The pathogenesis of PFAPA (periodic fever, aphthous stomatitis, pharyngitis, adenitis) syndrome is unknown as yet. In order to understand whether genes implicated in other auto-inflammatory diseases might be involved in the pathogenesis of PFAPA, all variants in the genes causing familial Mediterranean fever (FMF), tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS), and Hyper IgD syndrome were analyzed in children with PFAPA.

Patients and Methods:

All variants in MEFV, TNFRSF1A, and MVK were analyzed in 20 patients with PFAPA. PFAPA were diagnosed by previous published criteria. The findings of all analyses in PFAPA patients were compared with those of unaffected normal subjects (n=62).

Results:

In the 13 children of 20 with PFAPA, the heterozygous variants of MEFV (5 patients: E148Q-L110P, 2 patients: E148Q, 1 patient: E148Q-L110P/E148Q, 1 patient: E148Q-P369S-R408Q-E84K, 1 patient: E148Q-L110P-P369S-A408G, 1 patient: R202Q, 1 patient: P115R) were found. No variants belonging to TNFRSF1A or MVK were detected in children with PFAPA. The frequency of the E148Q-L110P variants in children with PFAPA was significantly higher than that observed in unaffected normal subjects (7/20 versus 8/62). The duration of the episodes of illness in PFAPA children with MEFV variants was shorter than that of patients without variants.

Conclusion:

Genes involved in the development and progression of MEFV may affect the incidence and the phenotype of PFAPA in children.

Keywords: PFAPA, MEFV, FMF, Variant, Japanese..


Article Information


Identifiers and Pagination:

Year: 2013
Volume: 7
First Page: 22
Last Page: 25
Publisher Id: TORJ-7-22
DOI: 10.2174/1874312901307010022

Article History:

Received Date: 22/1/2013
Revision Received Date: 9/3/2013
Acceptance Date: 14/3/2013
Electronic publication date: 19 /4/2013
Collection year: 2013

Article Metrics:

CrossRef Citations:
0

Total Statistics:

Full-Text HTML Views: 1065
Abstract HTML Views: 1157
PDF Downloads: 224
Total Views/Downloads: 2446

Unique Statistics:

Full-Text HTML Views: 602
Abstract HTML Views: 687
PDF Downloads: 154
Total Views/Downloads: 1443
Geographical View

© Taniuchi et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.


* Address correspondence to this author at the Department of Pediatrics, Kansai Medical University, Fumizonocho 10-15, Moriguchi, Osaka 570-8506, Japan; Tel: (+81)-6-6992-1001; Fax: (+81)-6-6992-9355; E-mail: taniuchi@takii.kmu.ac.jp




INTRODUCTION

In 1987 [1Marshall GS, Edwards KM, Lawton AR. PFAPA syndrome Pediatr Infect Dis J 1989; 8: 658-9.], Marshall firstly described, the PFAPA (periodic fever, aphthous stomatitis, pharyngitis and adenitis) syndrome, which is characterized by recurrent episodes of fever associated with cervical adenitis, pharyngitis and aphthous stomatitis. The prognosis of this disease has been reported to be better than that of another autoinflammatory diseases [2Wurster VM, Carlucci JG, Feder HM Jr, Edwards KM. Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome J Pediatr 2011; 159: 958-64.]. Corticosteroids are effective in controlling episodes of illness in PFAPA, but they do not cure the ailments or prevent recurrence of the symptoms of this syndrome [3Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children J Pediatr 1999; 135: 15-21.]. Interventions like tonsillectomy and administration of H2 blockers have been reported to be partially effective for prophylaxis [3Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children J Pediatr 1999; 135: 15-21.]. However the complete pathogenesis of PFAPA is unknown yet, and hence the therapeutic regimens have not yet been established for PFAPA [4Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome) Acta Paediatr 2010; 99: 178-84.].

Familial Mediterranean fever (FMF) is a recessively inherited disorder characterized by acute attacks of fever, and serositis usually lasting for 1–3 days. FMF is caused by mutations in the ME diterranean FeVer gene (MEFV), which encodes the protein pyrin (marenostrin)1[5Waheed A. The International FMF Consortium.Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever Cell journal 1997; 90: 797-807.,6Waheed A. French FMF Consortium.A candidate gene for familial Mediterranean fever Nat Genet 1997; 17: 25-31.]. Colchicine has been shown to be effective for prophylaxis in only 90% of the patients with FMF [7Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A. Familial Mediterranean Fever (FMF): from diagnosis to treatment Sante journal 2004; 14: 261-6.,8Soylemezoglu O, Arga M, Fidan K, et al. Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation J Rheumatol 2010; 37: 182-9.].

Recent studies have described that heterozygous variants of the MEFV gene were found in patients with PFAPA [9Padeh S, Brezniak N, Zemer D, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome J Pediatr 1999; 135: 98-101.-11Dagan E, Gershoni-Baruch R, Khatib I, Mori A, Brik R. MEFV.TNF1rA. CARD15 and NLRP3 mutation analysis in. PFAPA Rheumatol Int 2010; 30: 633-.]. However, it still remains unclear whether these variants are the causative factors of PFAPA.

The purpose of this study was to understand whether heterozygous variants of MEFV may be associated with the onset of PFAPA. We have also tried to understand whether these mutations act as accessory factors and modify the phenotype of patients with PFAPA.

PATIENTS AND METHODS

Twenty children with frequent PFAPA episodes who visited our pediatric outpatient clinic were consecutively selected over a 5-year period (from January 2005 to January 2010). The diagnosis of PFAPA syndrome was established using previously established criteria [1Marshall GS, Edwards KM, Lawton AR. PFAPA syndrome Pediatr Infect Dis J 1989; 8: 658-9.,3Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children J Pediatr 1999; 135: 15-21.,9Padeh S, Brezniak N, Zemer D, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome J Pediatr 1999; 135: 98-101.]. These criteria include recurring fevers associated with exudative tonsillitis, negative throat culture, and possibly, aphthous stomatitis and cervical lymphadenopathy. The additional clinical criteria included completely asymptomatic intervals between the episodes, normal growth and development and exclusion of FMF, Behcet’ s disease, and cyclic neutropenia. Oral low dose of prednisolone (0.3-0.5mg/kg/dose, 1 or 2 doses per day) was effective on all enrolled patients. MEFV, mevalonate kinase (MVK), and tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A) genes of all enrolled patients were sequenced. After obtaining a written informed consent approved by the Institutional Review Board of Kyoto University, peripheral blood was collected from all patients, and, if needed, their family members. Genomic DNA was extracted, and all the exons including exon-intron junctions of the MVK,MEFV, and TNFRSF1A genes were amplified by polymerase chain reaction and then sequenced using the ABI3130.

The results are shown as a mean ± SD or proportion, as appropriate. Differences between the groups in discrete variables were evaluated using Fisher’s exact test at 5% significance.

Two-sided P values were adjusted for multiplicity using Hochberg’s method.

Comparisons of continuous variables were done using unpaired Student’s t-test. All P values given are 2-sided. P values less than 0.05 were considered significant. Statistical calculation was conducted by SAS version 9.1.3.

RESULTS

Twenty patients (9 boys, 11 girls) diagnosed with PFAPA were followed up in our clinic. Thirteen of these patients had a single MEFV (M+ group). No variant of TNFRSF1A and MVK was detected in all patients. The genotypes of the MEFV gene in the 13 patients are seen in Table 1. The most common MEFV variant patterns seen were E148Q-L110P (5 patients) and E148Q (2 patients). One patient was homozygous of E148Q and heterozygous of L110P of MEFV. One patient was heterozygous of E148Q-P369S-R408Q. One patient was heterozygous for E148Q-P369S-R408Q-E84K. One patient had E148Q-L110P-P369S-R408Q. The minor variants, P115R and R202Q, were detected in 2 patients. More than 2 MEFV variants were on 1 allele in all PFAPA patients. In 7 patients, no MEFV mutations were found. The allele frequencies of E148Q, L110P, P369S, R408Q and G304R in 20 PFAPA patients were 0.3, 0.175, 0.075, 0.075 and 0, respectively (Table 3).

Table 1

The Genotypes of MEFV Genes of 13 Patients with PFAPA




Table 2

Clinical Characteristics of PFAPA Patients with Variants in the MEFV Gene Compared with those of PFAPA Patients without MEFV Variants




Table 3

Allele Frequencies of MEFV Variants in PFAPA Subjects and Normal Unaffected Subjects




Table 4

Frequencies of MEFV Variants in PFAPA Subjects and Normal Unaffected Subjects




Clinical and laboratory data were compared between MEFV positive group (n=13) and negative group (n=7) and are presented in Table 2. Patients carrying an MEFV variant showed shorter duration of episodes of illness than patients without variants (3.6±0.86 days versus 5.3±1.89 days, p=0.0174). No significant differences in all other clinical and laboratory data were found between the 2 groups (Table 2).

We also analyzed all sequences of MEFV genes in normal Japanese subjects (n=62). These individuals were healthy adult volunteers and had no recurrent episodes of fever. There was no difference in recruitment between the PFAPA patients and the control group. A comparison of these results between normal and PFAPA subjects is shown in Table 3. In normal individuals, no significant allele frequencies were observed for the 4 variants found in PFAPA patients. In addition, the frequencies of E148Q-L110P and P369S-R408Q in the 2 groups were compared. A significant difference in the frequency of these variants was observed between the 2 groups (Table 4, p = 0.043 and p = 0.026, respectively).

DISCUSSION

We studied 20 patients with PFAPA who were diagnosed by Marshall criteria [1Marshall GS, Edwards KM, Lawton AR. PFAPA syndrome Pediatr Infect Dis J 1989; 8: 658-9.]. Our aim was to access the roles of the predominant variants in genes that cause other febrile illnesses like FMF, TNF receptor-associated periodic syndrome (TRAPS) and the MVK deficiency. We did not find any incidence of variants of TRAPS and MVK deficiency in PFAPA patients. However several heterogeneous variants of MEFV were detected in 13 out of 20 patients with PFAPA. We analyzed the frequency of the E148Q-L110P and P369S-R408Q variants in PFAPA and control subjects. Our analyses indicate that the incidence of these 2 variants is significantly higher in patients with PFAPA than in normal individuals.

Amongst autoinflammatory disease, only PFAPA syndrome has been described as a non-inherited syndrome, since familial inheritance has not been reported in previous studies [3Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children J Pediatr 1999; 135: 15-21.,12Feder HM Jr, Bialecki CA. Periodic fever associated with aphthous stomatitis, pharyngitis and cervical adenitis Pediatr Infect Dis J 1989; 8: 186-7.,13Tasher D, Somekh E, Dalal I. PFAPA syndrome: new clinical aspects disclosed Arch Dis Child 2006; 91: 981-4.]. However some studies have reported familial cases that included siblings or a sibling and the sibling’s mother [14Sampaio IC, Rodrigo MJ, Monteiro Marques JG. Two siblings with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome Pediatr Infect Dis J 2009; 28: 254-5.-16Adachi M, Watanabe A, Nishiyama A, et al. Familial cases of periodic fever with aphthous stomatitis, pharyngitis, and cervical adenitis syndrome J Pediatr journal 2011; 158: 155-9.]. Therefore, the hereditary nature of this syndrome is still a matter of debate. With respect to the genetic factors that may cause the PFAPA syndrome, one study has strongly argued against the involvement of the MEFV gene [10Cazeneuve C, Geneviève D, Amselem S, Hentgen V, Hau I, Reinert P. MEFV gene analysis in PFAPA J Pediatr 2003; 143: 140-.], but another article [11Dagan E, Gershoni-Baruch R, Khatib I, Mori A, Brik R. MEFV.TNF1rA. CARD15 and NLRP3 mutation analysis in. PFAPA Rheumatol Int 2010; 30: 633-.] has shown that mutations of the MEFV genes were found in 27% of cases diagnosed with PFAPA syndrome on the basis of Marshall’s clinical criteria. Our observations of the high frequency (65%) of MEFV variants are in agreement with that reported by Dagan [11Dagan E, Gershoni-Baruch R, Khatib I, Mori A, Brik R. MEFV.TNF1rA. CARD15 and NLRP3 mutation analysis in. PFAPA Rheumatol Int 2010; 30: 633-.]. The differences in the findings may be attributed to the ethnic differences between the individuals studied, the small sized of the study, and the study population that was selected.

The L110P variant, which is located in exon 2, was first reported in FMF patients in 2000 [17Domingo C, Touitou I, Bayou A. Familial Mediterranean fever in the 'Chuetas' of Mallorca: a question of Jewish origin or genetic heterogeneity Eur J Hum Genet 2000; 8: 242-6.], and to date, several compound heterozygotes with other variants have been reported even in Japan [18Tsuchiya-Suzuki A, Yazaki M, Nakamura A, et al. Clinical and genetic features of familial Mediterranean fever in Japan J Rheumatol 2009; 36: 1671-6.,19Tomiyama N, Higashiuesato Y, Oda T, et al. MEFV mutation analysis of familial Mediterranean fever in Japan Clin Exp Rheumatol 2008; 26: 13-7.]. In contrast, although the role of the E148Q variant, which is located in exon 2, in FMF patients was controversial, a recent study concluded that the variant is just a benign polymorphism [20Tchernitchko D, Legendre M, Cazeneuve C, Delahaye A, Niel F, Amselem S. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever Hum Mutat 2003; 22: 339-40.]. In a Japanese study [18Tsuchiya-Suzuki A, Yazaki M, Nakamura A, et al. Clinical and genetic features of familial Mediterranean fever in Japan J Rheumatol 2009; 36: 1671-6.] of FMF patients, the most frequently observed MEFV variants observed were E148Q/M694I (25.0%), M694I (17.5%), and L110P/E148Q/M694I (17.5%). However, no patients had the M694V variant. These patterns are quite different from those in Mediterranean patients with FMF. The study also reported that the allele frequencies of E148Q, M694I, and L110P were 0.44, 0.35, and 0.31, respectively, and that these frequencies were significant difference from those seen in healthy controls. In our study, the allele frequencies of E148Q, L110P, and G304 were 0.3, 0.175, and 0, respectively, and these frequencies did not differ significantly between patients and healthy controls. No mutation at the M694I was detected in our cohorts of patients and controls. The allele frequency of L110P is higher in patients with PFAPA than in healthy controls; however, the difference is not significant. The frequency of the E148Q-L110P variant combination is significantly higher in the PFAPA group than in the healthy control group. If the E148Q variant is non-functional, the L110P variant may be associated with the onset of PFAPA syndrome.

In several types of inflammatory such as Behcet’s disease [21Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A. Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis Scand J Rheumatol 2007; 36: 48-52.], Crohn’s disease [22Uslu N, Yüce A, Demir H, et al. The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children Dig Dis Sci 2010; 55: 3488-94.], ulcerative colitis [23Giaglis S, Mimidis K, Papadopoulos V, et al. Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? Dig Dis Sci 2006; 51: 687-92.], Henoch-Schönlein purpura [24Gershoni-Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura J Pediatr journal 2003; 143: 658-1.,25Ozçakar ZB, Yalçinkaya F, Cakar N, et al. MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura J Rheumatol journal 2008; 35: 2427-9.] and the co-incidence of FMF variants has been investigated. These studies show increased incidence of genes involved in FMF in patients with these autoinflammatory diseases as well as the increased severity of the symptoms of each disease. On the other, in the patients with asthma, the incidence of FM mutation was decreased and the lower incidence correlated with reduced severity of symptoms [26Rabinovitch E, Harats D, Yaron P, et al. Familial Mediterranean fever gene and protection against asthma Ann Allergy Asthma Immunol 2007; 99: 517-21.]. Thus, FMF variants may affect the transition from Th2 to Th1 polarity in each disease. According to Berkun’s study [27Berkun Y, Levy R, Hurwitz A, et al. The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome Semin Arthritis Rheum 2011; 40: 467-72.], PFAPA episodes in carriers of MEFV variants were shorter compared to those in patients without variants. In MEFV variant-positive patients, the regular cyclic pattern of attacks and the occurrence of oral aphthae was lower than those in patients without MEFV variants. In the present study, we found that the only affected variable was the duration of PFAPA episodes. Although no significant differences were observed in the regular cyclic pattern of attacks and the occurrence of oral aphthae between the 2 groups, the duration of PFAPA episodes was shorter in the variant-positive group than in the variant-negative group.

Taken together, these results show that the MEFV gene may not affect the onset of several autoinflammatory diseases, but is likely to modify the intensity and the displayed phenotype in terms of disease symptoms.

In conclusion, the MEFV variants, viz. E148Q-L110P, P369-R408Q may be associated with the onset of PFAPA, and some MEFV variants may affect the phenotype of PFAPA.

CONFLICT OF INTEREST

The authors confirm that this article content has no conflict of interest.

ACKNOWLEDGEMENTS

The study was supported by the Mami Mizutani Foundation.

REFERENCES

[1] Marshall GS, Edwards KM, Lawton AR. PFAPA syndrome Pediatr Infect Dis J 1989; 8: 658-9.
[2] Wurster VM, Carlucci JG, Feder HM Jr, Edwards KM. Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome J Pediatr 2011; 159: 958-64.
[3] Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children J Pediatr 1999; 135: 15-21.
[4] Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome) Acta Paediatr 2010; 99: 178-84.
[5] Waheed A. The International FMF Consortium.Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever Cell journal 1997; 90: 797-807.
[6] Waheed A. French FMF Consortium.A candidate gene for familial Mediterranean fever Nat Genet 1997; 17: 25-31.
[7] Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A. Familial Mediterranean Fever (FMF): from diagnosis to treatment Sante journal 2004; 14: 261-6.
[8] Soylemezoglu O, Arga M, Fidan K, et al. Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation J Rheumatol 2010; 37: 182-9.
[9] Padeh S, Brezniak N, Zemer D, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome J Pediatr 1999; 135: 98-101.
[10] Cazeneuve C, Geneviève D, Amselem S, Hentgen V, Hau I, Reinert P. MEFV gene analysis in PFAPA J Pediatr 2003; 143: 140-.
[11] Dagan E, Gershoni-Baruch R, Khatib I, Mori A, Brik R. MEFV.TNF1rA. CARD15 and NLRP3 mutation analysis in. PFAPA Rheumatol Int 2010; 30: 633-.
[12] Feder HM Jr, Bialecki CA. Periodic fever associated with aphthous stomatitis, pharyngitis and cervical adenitis Pediatr Infect Dis J 1989; 8: 186-7.
[13] Tasher D, Somekh E, Dalal I. PFAPA syndrome: new clinical aspects disclosed Arch Dis Child 2006; 91: 981-4.
[14] Sampaio IC, Rodrigo MJ, Monteiro Marques JG. Two siblings with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome Pediatr Infect Dis J 2009; 28: 254-5.
[15] Valenzuela PM, Majerson D, Tapia JL, Talesnik E. Syndrome of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) in siblings Clin Rheumatol 009 ; 28: 1235-7.
[16] Adachi M, Watanabe A, Nishiyama A, et al. Familial cases of periodic fever with aphthous stomatitis, pharyngitis, and cervical adenitis syndrome J Pediatr journal 2011; 158: 155-9.
[17] Domingo C, Touitou I, Bayou A. Familial Mediterranean fever in the 'Chuetas' of Mallorca: a question of Jewish origin or genetic heterogeneity Eur J Hum Genet 2000; 8: 242-6.
[18] Tsuchiya-Suzuki A, Yazaki M, Nakamura A, et al. Clinical and genetic features of familial Mediterranean fever in Japan J Rheumatol 2009; 36: 1671-6.
[19] Tomiyama N, Higashiuesato Y, Oda T, et al. MEFV mutation analysis of familial Mediterranean fever in Japan Clin Exp Rheumatol 2008; 26: 13-7.
[20] Tchernitchko D, Legendre M, Cazeneuve C, Delahaye A, Niel F, Amselem S. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever Hum Mutat 2003; 22: 339-40.
[21] Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A. Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis Scand J Rheumatol 2007; 36: 48-52.
[22] Uslu N, Yüce A, Demir H, et al. The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children Dig Dis Sci 2010; 55: 3488-94.
[23] Giaglis S, Mimidis K, Papadopoulos V, et al. Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? Dig Dis Sci 2006; 51: 687-92.
[24] Gershoni-Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura J Pediatr journal 2003; 143: 658-1.
[25] Ozçakar ZB, Yalçinkaya F, Cakar N, et al. MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura J Rheumatol journal 2008; 35: 2427-9.
[26] Rabinovitch E, Harats D, Yaron P, et al. Familial Mediterranean fever gene and protection against asthma Ann Allergy Asthma Immunol 2007; 99: 517-21.
[27] Berkun Y, Levy R, Hurwitz A, et al. The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome Semin Arthritis Rheum 2011; 40: 467-72.

Endorsements



"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."


Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."


Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."


Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."


Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."


Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."


Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."


Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."


J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."


Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."


Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."


Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."


Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."


Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."


M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."


Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."


Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."


Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."


Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."


Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."


Jih Ru Hwu
(National Central University, Taiwan)


SCImago Journal Ranking

SCImago Journal & Country Rank

Browse Contents



Webmaster Contact: info@benthamopen.net
Copyright © 2019 Bentham Open